Announcements Trials
Browse Landscape

Phase

Phase 2 111Phase NA 92Phase 1 70Phase 1/2 43Phase 3 28Phase 4 18Phase EARLY_PHASE1 6Phase 2/3 4

Status

Recruiting 9Completed 8Terminated 6Unknown 4Withdrawn 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 108Thoracic 37Breast 37Other hematologic neoplasm 33Lymphoid 21Genitourinary 18Head & Neck 13Tumor-Agnostic 12Gynecologic 12CNS 10Plasma cell 7Myeloid 7Sarcoma 6Dermatologic 4Other neoplasm 3Endocrine 3Other solid neoplasm 2Other 2Classical hematology 2

Conditions

Melanoma 4Uveal Melanoma 1Retinal Diseases 1Macular Degeneration 1Hutchinson's Melanotic Freckle 1Choroid Diseases 1

Interventions

salicylhydroxamic acid 1molgramostim 1Triamcinolone Acetonide 1Ranibizumab 1Propranolol 1Interferon alpha-2 1Imiquimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Dermatologic × Clear all
NCT01088737 2019-08-13

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Medical University of Graz

Phase 2/3 Unknown
60 enrolled
Dermatologic

Melanoma, Hutchinson's Melanotic Freckle

NCT02962947 2016-11-15

MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients

Azienda Sanitaria di Firenze

Phase 2/3 Unknown
546 enrolled
Dermatologic

Melanoma

NCT01729663 2015-09-02

Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients

Laboratorio Pablo Cassará S.R.L.

Phase 2/3 Unknown
108 enrolled
Dermatologic

Melanoma

NCT00811200 2009-07-02

TORR

Leiden University Medical Center

Phase 2/3 Unknown
220 enrolled
Dermatologic

Uveal Melanoma, Macular Degeneration, Melanoma, Retinal Diseases, Choroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡